Prognostic factors among cancer patients with good performance status screened for phase I trials (Q81343760)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Prognostic factors among cancer patients with good performance status screened for phase I trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

main subject

phase I clinical trial

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Marie Vanseymortier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Marie-Edith Bonneterre

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Stéphanie Clisant

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Eric Dansin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Yvette Vendel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Régis Beuscart

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Jacques Bonneterre

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

22 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

53-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891337%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10637-007-9088-x

8 January 2020

exact match

0 references

cites work

Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site

1 reference

12 December 2020

Therapeutic response in phase I trials of antineoplastic agents

1 reference

12 December 2020

Phase I cancer trials: limitations and implications

1 reference

12 December 2020

CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.

1 reference

12 December 2020

Responses and toxic deaths in phase I clinical trials

1 reference

12 December 2020

Risks and benefits of phase 1 oncology trials, revisited

1 reference

12 December 2020

Prognostic factors for survival in patients treated in phase I clinical trials

1 reference

12 December 2020

Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience

1 reference

12 December 2020

Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis

1 reference

12 December 2020

Perceptions of cancer patients and their physicians involved in phase I trials

1 reference

12 December 2020

Race, nutritional status, and survival from breast cancer

1 reference

12 December 2020

Therapeutic and prognostic implications of peripheral blood lymphopenia in patients with Hodgkin's disease

1 reference

12 December 2020

Nutritional factors and survival of patients with oral cancer

1 reference

12 December 2020

A phase I trial on the ethics of phase I trials.

1 reference

12 December 2020

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

12 December 2020

Response rates, duration of response, and dose response effects in phase I studies of antineoplastics

1 reference

12 December 2020

Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas

1 reference

12 December 2020

Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials

1 reference

12 December 2020

Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma

1 reference

12 December 2020

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials

1 reference

12 December 2020